Latham & Watkins represented Zentalis Pharmaceuticals in the transaction.Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental…
